Fluridil degrades the androgen receptor.
    Research/Science 6/11/2025

    New to Fluridil? There is a guide in the encyclopedia. Read the guide →
    At a glance
    In this educational post, the primary subjects mentioned are the tone is 😐 neutral.

    Other terms

    Fluridil degrades androgen receptors, which are prevalent in the scalp and other tissues. People with androgenetic alopecia (AGA) may have higher expression of these receptors and 5AR activity in affected scalp areas.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      An Overview of Herbal Alternatives in Androgenetic Alopecia

      research An overview of herbal alternatives in androgenetic alopecia

      26 citations , April 2019 in “Journal of Cosmetic Dermatology”
      This review discusses the potential of herbal treatments like Saw palmetto, Green tea, and Rosemary as alternatives to conventional drugs for androgenetic alopecia, noting that these herbs may inhibit the 5-alpha-reductase enzyme and reduce hair loss with fewer side effects.
      Physiology and Medical Treatments for Alopecia

      research Physiology and Medical Treatments for Alopecia

      8 citations , April 2020 in “Facial Plastic Surgery Clinics of North America”
      This abstract explains that androgenetic alopecia, a common hair loss disorder influenced by genetics and hormones like dihydrotestosterone, has FDA-approved treatments including minoxidil, finasteride, and photolaser therapy, but its genetic basis and susceptibility to environmental factors remain complex.
      New Therapeutics in the Management of Androgenetic Alopecia

      research Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique

      March 2025 in “HAL (Le Centre pour la Communication Scientifique Directe)”
      This thesis investigates the underlying mechanisms and treatment options for androgenetic alopecia, highlighting the molecular roles of androgens and genetic predispositions, and evaluates current and emerging therapies, such as PROTACs and Janus Kinase inhibitors, to enhance patient management.
      Male Androgenetic Alopecia: Medical and Surgical Treatments

      research Male androgenetic alopecia (Part II)

      9 citations , February 2005 in “The Journal of Men's Health & Gender”
      This article reviews treatment options for male androgenetic alopecia, including their distinct aims of arresting progression, stimulating regrowth, and concealing hair loss, and reports no new clinical results.
      Androgenetic Alopecia: An Evidence-Based Treatment Update

      research Androgenetic Alopecia: An Evidence-Based Treatment Update

      151 citations , May 2014 in “American Journal of Clinical Dermatology”
      This review concluded that oral finasteride for men and topical minoxidil for both genders have the most evidence supporting their effectiveness and safety for treating androgenetic alopecia.
      Androgenetic Alopecia in Men: An Update on Genetics

      research Androgenetic Alopecia in Men: An Update On Genetics

      May 2024 in “Indian Journal of Dermatology”
      In this review, an association was reported between early-onset androgenetic alopecia and several health conditions like obesity and cardiovascular disease, with genetic and therapeutic research ongoing to improve treatment.